[1]Mueller PW, Phillips DL, Steinberg KK. Alanine aminopeptidase in Serum: automated optimized assay, and effects of age, sex, smoking, and alcohol consumption in a selected population[J]. Clin Chem, 1987, 33∶363-366.
|
[2]Favaloro EJ, Browning T, Nandurkar H. The hepatobiliary disease marker serum alanine aminopeptidase predominantly comprises an isoform of the haematological myeloid differentiation antigen and leukaemia marker CD-13/gp150[J].Clin Chim Acta, 1993, 81-90.
|
[3]Look AT, Ashmun RA, Shapiro LH, et al. Human myeloid plasma membrane glycoprotein CD-13 (gp150) is identical to aminopeptidase N[J]. J Clin Invest, 1989, 83∶1299-1307.
|
[4]Sanderink G, Artur Y, Schlete F, et al. Alanine aminopeptidase in serum:biological variations and reference limits[J]. Clin Chem, 1988, 34∶1422-1426.
|
[5]Sidorowicz W, Hsia W, Maslej-Zownir 0, et al. Multiple molecular forms of human alanine aminopeptidase:immunochemical properties[J].Clin Chim Acta, 1980, 107∶245-256.
|
[6]Bradstock KF, Favaloro EJ, Kabral A, et al. Myeloid progenitor surface antigen identified by monoclonal antibody[J].British Journal of Haematology, 1985, 61∶11-20.
|
[7]Sanderink G, Artur Y, Paille F et al. Clinical significance of a new isoform of serum alanine aminopeptidase; relationship with liver disease and alcohol consumption[J].Clin Chem Acta, 1989, 179∶23-32.
|
[8]Sanderink G, Artur Y, siest G. Human aminopeptidases: a review of the literature[J].Clin Chem Clin biochem, 1988, 26∶795-807.
|